
|Videos|May 17, 2022
Second-line Treatment Strategies for BRAF-mutant Metastatic Melanoma: Additional Patient Scenarios
Author(s)Michael Atkins, MD, Evan Lipson, MD
Dr Michael Atkins and Dr Evan Lipson discuss additional second- and third-line treatment options.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on OncLive
1
Daraxonrasib Plus Gemcitabine/Nab-Paclitaxel Generates Durable Responses in First-Line Metastatic PDAC
2
TroFuse-015 Meets Primary OS End Point With Sac-TMT in Third-Line or Later Gastroesophageal Adenocarcinoma
3
Dr Iyengar on Oral SERD Implementation in Early-Stage HR+ Breast Cancer
4
Dr Gutierrez on Considerations for Investigating SAR445877 in MSS CRC
5



